All hype, no research During CBC's undercover consultation, Seit admitted there was a lack of clinical human studies on BPC-157
Researchers working with extended time courses should validate stability for their own assay conditions rather than assuming a fixed window
BPC-157 has never undergone human clinical trials for any indication no phase 1 safety data, no pharmacokinetic studies, no efficacy trials
If you see something you'd like to flag with us or have additional questions, please don't hesitate to get in touchwe'd love to hear from you
Two 30mg vials cover approximately 5 weeks at 12mg per week, compared to three 20mg vials for the same duration
As part of the Khavinson peptide family developed in Russia, Pinealon offers a short-peptide approach to brain optimization focusing on the pineal gland's regulatory functions